Atlas Trials

To Evaluate SSD8432/ Ritonavir in Adults With COVID-19

Clinical trial NCT05369676 · COMPLETED

Trial details

NCT number
NCT05369676
Sponsor
Jiangsu Simcere Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
COVID-19 Patients
Start date
2022-05-12
Primary completion
2022-08-29
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.